Show simple item record

dc.contributor.authorBaharfard, N
dc.contributor.authorMohammad Kazem Shiroodi, Fotoohi, F
dc.contributor.authorSamangooie, S
dc.contributor.authorIsa Neshandar Asli, Eghtesadi-Araghi, P
dc.contributor.authorJavadi, H
dc.contributor.authorSemnani, S
dc.contributor.authorAmini, A
dc.contributor.authorAssadi, M
dc.date.accessioned2018-08-26T09:31:15Z
dc.date.available2018-08-26T09:31:15Z
dc.date.issued2011
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/56963
dc.description.abstractIntroduction: The aim of the present study was to evaluate technetium-99m sestamibi single photon emission tomography (SPECT) myocardial perfusion imaging (MPI) and its association with some clinical and laboratory parameters in an asymptomatic systemic lupus erythematosus (SLE) population. Materials and Methods : Twenty-one subjects with SLE and no suspected or documented coronary artery disease (CAD) accomplished myocardial perfusion imaging. Some SLE and CAD parameters were also evaluated in association with myocardial SPECT. Results: Twenty-one women with a diagnosis of SLE (mean age 36.9 ± 12.8) entered the study. All patients were in the low-risk category for CAD pretest; however, abnormal myocardial perfusion results were found in eight (38%) patients. Amongst the traditional CAD risk factors, there was a significant association between the presence of dyslipidemia and myocardial perfusion abnormalities (P= 0.047). However, we found no significant association between other traditional and SLE-specific risk factors. Conclusion: This study's significant finding was that asymptomatic CAD is common in SLE patients, even in those thought to be low risk for CAD and in the absence of cardiac symptoms. © The Author(s) 2010.
dc.language.isoEnglish
dc.relation.ispartofPerfusion
dc.subjectC reactive protein
dc.subjectcardiolipin antibody
dc.subjectcomplement
dc.subjectcorticosteroid
dc.subjectdipyridamole
dc.subjectdouble stranded DNA antibody
dc.subjectmethoxy isobutyl isonitrile technetium tc 99m
dc.subjectadult
dc.subjectantibody blood level
dc.subjectarticle
dc.subjectblood cell count
dc.subjectbody mass
dc.subjectclinical article
dc.subjectcoronary artery disease
dc.subjectcoronary risk
dc.subjectcorticosteroid therapy
dc.subjectdiabetes mellitus
dc.subjectdisease duration
dc.subjectdisease severity
dc.subjectdyslipidemia
dc.subjectfamily history
dc.subjectfemale
dc.subjectheart muscle perfusion
dc.subjecthuman
dc.subjecthypertension
dc.subjectmenopause
dc.subjectmyocardial disease
dc.subjectmyocardial perfusion imaging
dc.subjectpharmacologic stress testing
dc.subjectpriority journal
dc.subjectprotein blood level
dc.subjectproteinuria
dc.subjectsingle photon emission computer tomography
dc.subjectsmoking
dc.subjectsystemic lupus erythematosus
dc.subjectAdult
dc.subjectCoronary Artery Disease
dc.subjectFemale
dc.subjectHumans
dc.subjectLupus Erythematosus, Systemic
dc.subjectMiddle Aged
dc.subjectMyocardial Perfusion Imaging
dc.subjectRisk Factors
dc.subjectTechnetium Tc 99m Sestamibi
dc.subjectTomography, Emission-Computed, Single-Photon
dc.subjectYoung Adult
dc.titleMyocardial perfusion imaging using a technetium-99m Sestamibi in asymptomatic and low risk for coronary artery disease patients with diagnosed systemic lupus erythematosus
dc.typeArticle
dc.citation.volume26
dc.citation.issue2
dc.citation.spage151
dc.citation.epage157
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1177/0267659110389844


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record